LicianPro

BOSTON SCIENTIFIC CORP ·

BSX 8-K 2026-09-23

BOSTON SCIENTIFIC CORP (BSX) 8-K dated 2026-09-23 — accession 0000885725-26-000061.

BOSTON SCIENTIFIC CORP (BSX) is a medical devices company listed on US.

BOSTON SCIENTIFIC CORP filed a 8-K on 2026-09-23. Accession 0000885725-26-000061.

This 8-K covers: Director/officer change (Item 5.02). SEC EDGAR holds the official filing and its exhibits.

Latest reported BSX revenue for 2025-12-31 was $20.07B. Net income was $2.89B. Revenue was up 19.9% from 2024-12-31 to 2025-12-31. BSX currently screens at market cap $71.81B and trailing P/E 18.5.

Not investment advice. The BSX SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr